GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » Accounts Receivable

Organon Pharma Indonesia PT (ISX:SCPI) Accounts Receivable : Rp0.00 Mil (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Organon Pharma Indonesia PT's accounts receivables for the quarter that ended in . 20 was Rp0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Organon Pharma Indonesia PT's Net-Net Working Capital per share for the quarter that ended in . 20 was RpN/A.


Organon Pharma Indonesia PT Accounts Receivable Historical Data

The historical data trend for Organon Pharma Indonesia PT's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT Accounts Receivable Chart

Organon Pharma Indonesia PT Annual Data
Trend
Accounts Receivable

Organon Pharma Indonesia PT Quarterly Data
Accounts Receivable

Organon Pharma Indonesia PT Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Organon Pharma Indonesia PT Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Organon Pharma Indonesia PT's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Organon Pharma Indonesia PT's accounts receivable are only considered to be worth 75% of book value:

Organon Pharma Indonesia PT's Net-Net Working Capital Per Share for the quarter that ended in . 20 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(+0.75 * +0.5 * -N/A
--)/0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Organon Pharma Indonesia PT Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920
Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines